Grant Awards in April & October 2008
Preface >>
Facts and Figures >>
| Principal Investigator | Project Title/Link |
| 1. Grant Awards in Cycle XIX and XX | |
| 1.1 Conventional ROTRF Research Grants - Cycle XIX | |
|
Prof. Leszek Ignatowicz Medical College of Georgia, Augusta, USA |
Origin and Allocation of Regulatory T cells upon Graft Rejection or Acceptance |
|
Prof. Victor Laubach University of Virginia, Charlottesville, USA |
Prevention of Lung Transplant Injury by Adenosine Receptor Activation |
|
Dr Andrew Luster Massachusetts General Hospital, Charlestown, USA |
Chemokine-Mediated Control of Effector and Regulatory T Cells in Lung Rejection |
|
Prof. Anette Melk Medizinische Hochschule Hannover, Kinderklinik, Hannover, Germany |
Overcoming Senescence Mechanisms Will Lead to Better Renal Graft Survival |
|
Prof. Wei-Ping Min University of Western Ontario, London, Canada |
Prevention of Organ Injury and Rejection in Transplantation |
|
Prof. Andrey Sorokin Medical College of Wisconsin, Milwaukee, USA |
Prevention of Virus-associated Nephropathy after Renal Transplantation |
| 1.2 Conventional ROTRF Research Grants - Cycle XX | |
|
Dr Ignacio Anegon INSERM U643, Nantes, France |
Analysis of Cells That Inhibit Anti-graft Immune Responses |
|
Dr David Russell University of Washington, Seattle, USA |
Histocompatible Stem Cells for Transplantation |
|
Dr Anna Valujskikh Cleveland Clinic, Cleveland, USA |
Alloantibody Production in Sensitized Transplant Recipients |
|
Dr Barbara A. Wasowska Johns Hopkins University, Baltimore, USA |
Sialylated IgG Antibodies Inhibit Inflammation and Graft Rejection |
| 1.3 Clinical ROTRF Research Grants - Cycle XIX | |
|
Prof. Annette Boehler University Hospital, Zurich, Switzerland |
Confocal Microscopy after Lung Transplantation: Specific Findings during Rejection? |
|
Dr Diana Metes University of Pittsburgh, Pittsburgh, USA |
Immune Cells for Therapy of Post-transplant Lymphoproliferative Disorders in Pediatric Transplant Patients |
| 1.4 Clinical ROTRF Research Grants - Cycle XX | |
|
Dr Neal N. Iwakoshi Emory University, Atlanta, USA |
Transplant Rejection Mediated by Antibody |
|
Dr David Neujahr Emory University, Atlanta, USA |
Predictive Modeling of Outcomes in Lung Transplantation |
|
Dr Emmanuel Zorn Massachusetts General Hospital, Boston, USA |
Characterization of Immune Cells Contributing to the Rejection of Transplanted Kidneys in Humans |
| 2. ROTRF/JDRF Joint Grant Awards - Cycle XIX and XX | |
| 2.1 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XIX | |
|
Dr Karen Dwyer St. Vincent’s Hospital, Melbourne, Australia |
Prolonging Pancreatic Islet Cell Survival following Transplantation |
| 2.2 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XX | |
|
Dr Jacques Thibodeau University Montreal, Montreal, Canada |
New Immunological Avenues to Improve Allograft Survival |
| 2.3 Clinical ROTRF/JDRF Joint Grant Awards - Cycle XIX | |
|
Mr Paul Johnson University of Oxford, Oxford, UK |
Optimisation of Human Pancreatic Islet Isolation |
